Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical…
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage…
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal…
XRP News: Vaultro Finance Presale on XRP ledger Skyrockets Past 50%, As Investors Race to Own $VLT Token
SINGAPORE , June 15, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has just…
Sunny Mining achieves breakthrough AI-driven technology,Becoming a profitable milestone in the cloud mining industry
San Francisco County, California , June 13, 2025 (GLOBE NEWSWIRE) -- Recently,…
Psychic Hotline | Accurate Psychic Phone Readings by Certified Experts Special 2025 Announcement
San Francisco, CA, June 13, 2025 (GLOBE NEWSWIRE) -- San Francisco, CA,…
![Real IQ Test Online | Quick IQ Test with Instant Results [Accurate & Legit] Special 2025 Announcement](https://i0.wp.com/ml.globenewswire.com/Resource/Download/43db9f2e-a3be-4ca2-89e5-2abb41f352d8?w=420&resize=420,280&ssl=1 "Real IQ Test Online | Quick IQ Test with Instant Results [Accurate & Legit] Special 2025 Announcement")
Real IQ Test Online | Quick IQ Test with Instant Results [Accurate & Legit] Special 2025 Announcement
San Francisco, CA, June 13, 2025 (GLOBE NEWSWIRE) -- Â Quick IQ Test…
Payday Ventures is Leading as the Best No Credit Check Loans Platform with No Credit Check Loans Guaranteed Approval in 2025
New York City, June 13, 2025 (GLOBE NEWSWIRE) -- Searching for the…
D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth
Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced…
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…